Cefuroxime contains an active component as cefuroxime. It is an antibiotic medication used to treat a variety of bacterial infections. It belongs to the class of antibiotics known as cephalosporins. This medication has a broad spectrum of activity against gram-positive and gram-negative bacteria. Cefuroxime received its initial approval from the U.S. Food and Drug Administration (FDA) on June 13, 1984. This approval was for the intravenous (IV) formulation of cefuroxime, which treats various bacterial infections.

This medication has a broad spectrum of activity against gram-positive and gram-negative bacteria. This medication is commonly used to treat respiratory tract infections, such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and certain sexually transmitted infections like gonorrhea.

To use cefuroxime, follow the instructions provided by your healthcare provider or as indicated on the medication label. It is available in various forms, including extended-release tablets and intravenous (IV) injections. If taking the oral tablets, swallow them whole with a full glass of water, with or without food, as directed. If using extended-release tablets, do not crush or chew them. For intravenous administration, it is typically administered by a healthcare professional in a clinical setting. The dosage and duration of treatment will depend on the type and severity of the infection.

Cefuroxime, like any medication, can cause side effects. Common side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain. Headaches, dizziness, and skin rash are also reported. These side effects are generally mild and resolve on their own. However, more serious side effects can occur, albeit rarely, including severe allergic reactions, liver dysfunction, and blood disorders.

Cefuroxime carries certain warnings that should be considered when using the medication. These include the possibility of severe allergic reactions, such as anaphylaxis, which requires immediate medical attention. There is also a risk of developing Clostridium difficile-associated diarrhea, a potentially serious condition characterized by persistent diarrhea. This medication may cause skin reactions ranging from mild rashes to severe conditions like Stevens-Johnson syndrome or toxic epidermal necrolysis. This medication can occasionally lead to liver dysfunction, as indicated by elevated liver enzymes. Although rare, central nervous system effects have been reported, such as confusion or seizures. Lastly, prolonged or repeated use of this medicine can result in the overgrowth of non-susceptible organisms, including fungi, leading to secondary infections. 

When using Cefuroxime, it is important to be aware of potential warnings. It is important to be aware of these potential skin reactions and seek medical help if any skin changes occur and monitor for these symptoms, and contact a healthcare provider if they arise. Vigilance and prompt reporting of new or worsening symptoms are essential to ensure cefuroxime's safe and effective use. Contact your healthcare provider if you experience severe or persistent diarrhea during or after treatment. Avoid alcohol consumption while taking cefuroxime, as it can interact with the medication and potentially increase the risk of side effects. Adhering to these precautions and following your healthcare provider's guidance can help ensure the safe and effective use of cefuroxime.

Inform your healthcare provider about any known allergies or sensitivities to cephalosporin antibiotics and any other medications or substances you are currently taking. Additionally, disclose your medical history, especially if you have a history of kidney disease, liver disease, gastrointestinal disorders, or blood clotting disorders. Use cefuroxime with caution if you have a history of severe allergic reactions or asthma. Pregnant and breastfeeding women should consult a doctor before taking it. It is crucial to complete the full course of treatment as prescribed and not to skip any doses, even if symptoms improve, to ensure the infection is fully treated. If you develop severe or persistent diarrhea during or after treatment, contact your healthcare provider, as it could be a sign of a serious intestinal infection. It is advisable to consult a healthcare professional to determine the appropriate dosage for both geriatric and pediatric populations.

1. Flynn Pharma Ltd, Electronic Medicines Compendium (EMC), [Revised on 05 Jun 2023] [Accessed on 18th Jun 2023], https://www.medicines.org.uk/emc/product/149/pil#gref
2. Covis Pharmaceuticals Inc, US Food & Drug Administration, [Revised on 2013] [Accessed on 18th Jun 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050558s069,050643s022lbl.pdf
3. Camille E. Beauduy, Lisa G. Winston, Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics, Lange’s Basic & Clinical Pharmacology, 14th Edition, 2018, 795-814.

The drug information on this page is different from medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.